T-box transcription factor 21 (T-bet)

T-box transcription factor 21 (T-bet) is a master regulatory transcription factor encoded by the TBX21 gene. It plays a central role in orchestrating type 1 immune responses by promoting differentiation toward the Th1 lineage in CD4+ helper T cells while repressing alternative fates such as Th2 and Th17. Beyond CD4+ lymphocytes, it regulates development/maturation/functionality in CD8+ cytotoxic lymphocytes and natural killer (NK) cells; it also influences B cell class switching to IgG2a and controls key proinflammatory cytokines including interferon-gamma. Dysregulation has been implicated in various inflammatory diseases—including asthma/allergy—and impacts host defense against infections/tumors. While not directly targeted by current drugs, its function is shaped by upstream cytokine signaling pathways commonly manipulated therapeutically.

Other names

T-betTBX21T-cell-specific T-box transcription factorTranscription factor TBLYMT-box protein 21

Drugs or interventions that modulate upstream cytokines/signaling pathways can alter the expression/activity of T-bet. For example: Cytokine therapies targeting IFNγ or IL‑12 can upregulate/downregulate its activity. JAK/STAT pathway inhibitors may affect downstream induction/functionality. No direct pharmacological inhibitors/modulators for clinical use are described.